Poster Tour 3: Cannabis, Ketamine and Psychedelic Research
Tracks
.
| Monday, November 9, 2026 |
| 12:30 PM - 1:05 PM |
| Exhibition Hall |
Overview
Posterboards 7, 8, 9, 10
Speaker
Dr Stephen Bright
Senior Lecturer
Edith Cowan University
Poster Tour 3: Introduction and Welcome
12:30 PM - 12:35 PM
Dr Stephen Bright is a psychologist who has worked in the AOD field for over 20 years. He is currently Senior Lecturer at Edith Cowan University where he oversees the teaching of the Addiction Studies major. Dr Bright is also WA Assistant Commissioner for AOD. Stephen is a strong advocate of harm reduction and an evidence-based approach to AOD legislation. He has published research on the intersect between new and emerging drugs and drug policy, older adults and AOD, drug checking and psychedelic-assisted psychotherapies. Dr Bright established Australia’s first not-for-profit psychedelic research company, Psychedelic Research in Science & Medicine Ltd. He has since conducted clinical trials using MDMA and psilocybin to treat treatment refractory PTSD and depression, respectively. Given the recent changes to authorised prescribers’ scheme in Australia, Stephen now trains clinicians in the provision of psychedelic-assisted psychotherapies and consultancy to prospective authorised prescribers.
Ms Danielle Dawson
Phd Candidate
The University Of Queensland
Self-reported reasons for medical and nonmedical cannabis use in Australia: findings from the 2023 International Cannabis Policy Study
12:35 PM - 12:40 PM
Danielle is a PhD candidate at the National Centre for Youth Substance Use Research. Her clinical experience in the field of psychology has led to a deep interest in cannabis and public health. Her research investigates the epidemiology of medicinal cannabis in Australia.
Mr Antoni Pazeski
Research Officer
Hunter New England Local Health District, Drug and Alcohol Clinical Services
From Click to Clinic: How recruitment pathways shape demographic composition in a phase III multisite randomised controlled trial: The CBD for CUD study.
12:40 PM - 12:45 PM
Antoni Pazeski is an early career researcher working at Hunter New England Local health district, working on qualitative and quantitative studies in drug and alcohol addiction.
Arshman S Sahid early career researcher working at South East Sydney Local health district working on clinical trials in addiction.
Mr Sam Lasham
Phd Candidate
University Of Auckland
A survey exploration of psilocybin mushroom use in Aotearoa New Zealand
12:45 PM - 12:50 PM
Sam is a PhD candidate at the University of Auckland researching psilocybin mushroom use in Aotearoa through a harm‑reduction lens. He is also national coordinator of Students for Sensible Drug Policy Aotearoa, a Psilver Linings NZ board member, and member of Harm Reduction Coalition Aotearoa and the Global Psychedelics Consortium.
Dr Anjali Bhardwaj
Clinical Trial Lead
University of Sydney/ South Eastern Sydney Local Health District
A Phase II Study of Medicinal Cannabis Products in the Treatment of Chronic Pain in Patients with Opioid Dependence: a Study Protocol
12:50 PM - 12:55 PM
Anjali is a Clinical Trial Lead at the University of Sydney and a research expert at leading clinical trials with Medicinal Cannabis.
Tour Facilitator
Stephen Bright
Senior Lecturer
Edith Cowan University